Implications of continued response after autologous stem cell transplantation for multiple myeloma-Reference-Cited by-同舟云学术

Implications of continued response after autologous stem cell transplantation for multiple myeloma

Published:2013-09-05 Issue:10 Volume:122 Page:1746-1749
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Gonsalves Wilson I.¹,Gertz Morie A.¹,Dispenzieri Angela¹,Lacy Martha Q.¹,Lin Yi¹,Singh Preet P.¹,Gupta Vinay¹,Hayman Suzanne R.¹,Buadi Francis K.¹,Dingli David¹,Kapoor Prashant¹,McCurdy Arleigh R.¹,Kumar Shaji K.¹

Affiliation:

1. Divisions of Hematology and Blood and Marrow Transplantation, Mayo Clinic, Rochester, MN

Abstract

Key Points A continued monoclonal protein response after ASCT in the absence of further therapy is prognostic in MM patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/10/1746/1367567/1746.pdf

Reference21 articles.

1. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.;Blade;Br J Haematol,1998

2. Stem cell transplantation for multiple myeloma.;Kumar;Curr Opin Oncol,2009

3. International uniform response criteria for multiple myeloma.;Durie;Leukemia,2006

4. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.;Kyle;Leukemia,2009

5. Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie.;Kapoor;Mayo Clinic Proc,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation;Leukemia & Lymphoma;2023-09

2. Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem‐cell transplantation for high‐risk newly diagnosed multiple myeloma;American Journal of Hematology;2022-02-09

3. Relationship of tumor load parameters before and after autologous stem cell transplantation with clinical prognosis in transplant-eligible patients with multiple myeloma: A retrospective analysis;Leukemia Research;2022-01

4. Early and late relapses of multiple myeloma after autologous haematopoietic stem cell transplantation;Russian journal of hematology and transfusiology;2021-12-01

5. New Targeted Therapies for Multiple Myeloma Under Clinical Investigation;Resistance to Targeted Anti-Cancer Therapeutics;2021